The MYCN Polyclonal Antibody (PAC061450) is a valuable tool for researchers studying MYCN, a gene that plays a critical role in the development and progression of various cancers, particularly neuroblastoma. This antibody, produced in rabbits, is highly specific to human MYCN and has been validated for use in Western blot applications.MYCN is a transcription factor that is essential for normal development, but its overexpression is associated with aggressive tumor growth and poor prognosis in cancer patients. By targeting MYCN, researchers can better understand the mechanisms driving cancer progression and potentially discover new therapeutic targets for cancer treatment.
This antibody recognizes the MYCN protein, allowing for precise detection and analysis in a variety of cell types. Its high specificity and sensitivity make it an ideal tool for studying MYCN in both basic research and clinical applications. With the MYCN Polyclonal Antibody, researchers can delve deeper into the role of MYCN in cancer biology and explore new avenues for cancer therapy development.
Western Blot. Positive WB detected in Recombinant protein. All lanes: mycn antibody at 2.2µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 41 kDa. Observed band size: 48 kDa.
